UTICA, NY--(Marketwired - Oct 23, 2014) - CONMED Corporation (NASDAQ: CNMD)
• Sales of $175.0 Million
• Diluted earnings per share (GAAP) $0.07
• Adjusted EPS of $0.44, growth of 10%
• Company reaffirms guidance
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter ended September 30, 2014.
Third Quarter 2014 Financial Highlights:
• Sales of $175.0 million decreased 2.4% as reported versus the prior year period.
• Diluted earnings per share (GAAP) were $0.07, compared to $0.20 in the third quarter of 2013 and were affected by special items as described below.
• Adjusted diluted earnings per share of $0.44 increased 10% compared to $0.40 in the prior year period.
• Gross profit margin on a GAAP basis grew 190 basis points to 55.1%. Excluding restructuring costs, adjusted gross profit margin expanded to 55.9% from 55.1% reflecting the continued benefit from the manufacturing consolidation efforts.
Help employers find you! Check out all the jobs and post your resume.
• Sales of $175.0 Million
• Diluted earnings per share (GAAP) $0.07
• Adjusted EPS of $0.44, growth of 10%
• Company reaffirms guidance
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter ended September 30, 2014.
Third Quarter 2014 Financial Highlights:
• Sales of $175.0 million decreased 2.4% as reported versus the prior year period.
• Diluted earnings per share (GAAP) were $0.07, compared to $0.20 in the third quarter of 2013 and were affected by special items as described below.
• Adjusted diluted earnings per share of $0.44 increased 10% compared to $0.40 in the prior year period.
• Gross profit margin on a GAAP basis grew 190 basis points to 55.1%. Excluding restructuring costs, adjusted gross profit margin expanded to 55.9% from 55.1% reflecting the continued benefit from the manufacturing consolidation efforts.
Help employers find you! Check out all the jobs and post your resume.
